 SOUTH SAN FRANCISCO, Calif., March 31, 2021 PRNewswire -- Titan Pharmaceuticals, Inc. NASDAQ: TTNP announced today that it has filed its annual report on Form 10-K for the fiscal year ended December 31, 2020 with the Securities and Exchange Commission SEC. 